CORRELATION OF UGT 1A1*28 MUTATIONS WITH OUTCOME AND TOXICITY IN NEWLY DIAGNOSED GBM PATIENTS TREATED WITH RADIOTHERAPY, IRINOTECAN, AND CARMUSTINE ON N997D, A PHASE II NORTH CENTRAL CANCER TREATMENT GROUP (NCCTG) STUDY

被引：0
|
作者：
Jaeckle, Kurt [1 ]
Ballman, Karla [2 ]
Felten, Sara [2 ]
Ames, Matthew [2 ]
Buckner, Jan [2 ]
机构：
[1] Mayo Fdn Med Educ & Res, Jacksonville, FL USA
[2] Mayo Fdn Med Educ & Res, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：844 / 844
页数：1
相关论文
共 5 条
  • [1] N997D: Pilot trial of CPT11 during RT followed by CPT11 and BCNU in newly diagnosed gliablastoma (GBM) patients: A North Central Cancer Group (NCCTG) Study
    Jaeckle, KA
    Ballman, KV
    Schomberg, P
    Uhm, J
    Schiethauer, B
    Giannini, C
    Felton, S
    Brown, P
    Jan, BC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 117S - 117S
  • [2] Correlation of response with survival endpoints in patients with newly diagnosed and recurrent glioblastoma (GBM) treated on prospective North Central Cancer Treatment Group (NCCTG) clinical trials
    Jaeckle, K. A.
    Wu, W.
    Kosel, M.
    Flynn, P. J.
    Buckner, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.
    Ma, Daniel
    Galanis, Evanthia
    Schiff, David
    Wu, Wenting
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Flynn, Patrick J.
    Buckner, Jan C.
    Sarkaria, Jann Nagina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Comparison of outcome of patients with newly diagnosed and recurrent gliomas treated on north central cancer treatment group (NCCTG) phase II and III trials within the community as compared to an academic medical center
    Jaeckle, K. A.
    Furth, A. F.
    Wu, W.
    Ballman, K. V.
    Flynn, P. J.
    Brown, P. D.
    Galanis, E.
    Buckner, J. C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 406 - 407
  • [5] PHASE II EVALUATION OF GEFITINIB IN PATIENTS WITH NEWLY DIAGNOSED GRADE 4 ASTROCYTOMA: MAYO/NORTH CENTRAL CANCER TREATMENT GROUP STUDY N0074
    Uhm, Joon H.
    Ballman, Karla V.
    Wu, Wenting
    Giannini, Caterina
    Krauss, J. C.
    Buckner, Jan C.
    James, C. D.
    Scheithauer, Bernd W.
    Behrens, Robert J.
    Flynn, Patrick J.
    Schaefer, Paul L.
    Dakhill, Shaker R.
    Jaeckle, Kurt A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 347 - 353
1